{"id":64602,"date":"2026-05-07T13:27:11","date_gmt":"2026-05-07T05:27:11","guid":{"rendered":"https:\/\/flcube.com\/?p=64602"},"modified":"2026-05-07T13:27:12","modified_gmt":"2026-05-07T05:27:12","slug":"amoytop-biotech-launches-rmb-1-53-billion-convertible-bond-offering-to-fuel-rd-and-manufacturing-expansion","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=64602","title":{"rendered":"Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion"},"content":{"rendered":"\n<p><strong>Amoytop Biotech Co. Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/688278:SHA\">SHA: 688278<\/a>) released its <strong>prospectus for convertible bond issuance<\/strong> to unspecified eligible investors, targeting total proceeds of <strong>RMB 1.53 billion<\/strong> (approximately <strong>USD 225.3 million<\/strong>). The capital will be allocated across three strategic initiatives: <strong>new drug research and development<\/strong>, construction of a <strong>Biotech Innovation Integration Center<\/strong>, and <strong>expansion and renovation<\/strong> of the company&#8217;s <strong>innovative drug manufacturing facility<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financing-details\">Financing Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Issuer<\/strong><\/td><td>Amoytop Biotech Co. Ltd. (SHA: 688278)<\/td><\/tr><tr><td><strong>Instrument<\/strong><\/td><td>Convertible bonds to unspecified eligible investors<\/td><\/tr><tr><td><strong>Total Proceeds<\/strong><\/td><td>RMB 1.53 billion (USD 225.3 million)<\/td><\/tr><tr><td><strong>Primary Use of Proceeds<\/strong><\/td><td>New drug R&amp;D, Biotech Innovation Integration Center, manufacturing facility expansion<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>7 May 2026<\/td><\/tr><tr><td><strong>Listing Venue<\/strong><\/td><td>Shanghai Stock Exchange STAR Market<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-capital-allocation-strategy\">Capital Allocation Strategy<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>New Drug Research &amp; Development:<\/strong> Accelerating pipeline candidates through preclinical and clinical stages, focusing on innovative therapeutic modalities<\/li>\n\n\n\n<li><strong>Biotech Innovation Integration Center:<\/strong> Establishing a state-of-the-art research hub to foster collaboration between discovery, development, and commercialization teams<\/li>\n\n\n\n<li><strong>Manufacturing Facility Enhancement:<\/strong> Expanding and renovating production lines to support current and future innovative drug portfolio, ensuring compliance with international quality standards<\/li>\n<\/ul>\n\n\n\n<p>This strategic capital raise reflects Amoytop&#8217;s commitment to vertical integration across the biopharmaceutical value chain\u2014from discovery through commercial-scale manufacturing.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-strategic-implications\">Market Context &amp; Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>China Biotech Funding Environment:<\/strong> Despite market volatility, well-positioned biotech companies continue to access capital through innovative financing structures like convertible bonds, which offer flexibility for both issuers and investors.<\/li>\n\n\n\n<li><strong>Vertical Integration Strategy:<\/strong> By investing simultaneously in R&amp;D, innovation infrastructure, and manufacturing capacity, Amoytop is building a <strong>fully integrated biotech platform<\/strong> capable of end-to-end drug development and commercialization.<\/li>\n\n\n\n<li><strong>Competitive Positioning:<\/strong> The <strong>Biotech Innovation Integration Center<\/strong> represents a significant step toward establishing Amoytop as a regional innovation hub, potentially attracting partnerships and talent from across the Asia-Pacific biotech ecosystem.<\/li>\n\n\n\n<li><strong>Manufacturing Scale-Up:<\/strong> The facility expansion addresses growing demand for <strong>high-quality biologics manufacturing capacity<\/strong> in China, positioning Amoytop to serve both domestic and international markets.<\/li>\n<\/ul>\n\n\n\n<p>The convertible bond structure provides Amoytop with immediate access to growth capital while offering investors potential equity upside, aligning stakeholder interests with the company&#8217;s long-term innovation strategy.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding financing activities, capital allocation, and strategic initiatives. Actual results may differ due to risks including market conditions, regulatory approvals, and execution challenges.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/688278_20260507_ZL53.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 688278_20260507_ZL53.\"><\/object><a id=\"wp-block-file--media-4a3de84c-fdc3-4312-be65-c429302898ce\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/688278_20260507_ZL53.pdf\">688278_20260507_ZL53<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/688278_20260507_ZL53.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-4a3de84c-fdc3-4312-be65-c429302898ce\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Amoytop Biotech Co. Ltd. (SHA: 688278) released its prospectus for convertible bond issuance to unspecified&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[470,20,1232],"class_list":["post-64602","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-amoytop-biotech","tag-finance","tag-sha-688278"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Amoytop Biotech Co. Ltd. (SHA: 688278) released its prospectus for convertible bond issuance to unspecified eligible investors, targeting total proceeds of RMB 1.53 billion (approximately USD 225.3 million). The capital will be allocated across three strategic initiatives: new drug research and development, construction of a Biotech Innovation Integration Center, and expansion and renovation of the company&#039;s innovative drug manufacturing facility.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=64602\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion\" \/>\n<meta property=\"og:description\" content=\"Amoytop Biotech Co. Ltd. (SHA: 688278) released its prospectus for convertible bond issuance to unspecified eligible investors, targeting total proceeds of RMB 1.53 billion (approximately USD 225.3 million). The capital will be allocated across three strategic initiatives: new drug research and development, construction of a Biotech Innovation Integration Center, and expansion and renovation of the company&#039;s innovative drug manufacturing facility.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=64602\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-07T05:27:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-07T05:27:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64602#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64602\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion\",\"datePublished\":\"2026-05-07T05:27:11+00:00\",\"dateModified\":\"2026-05-07T05:27:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64602\"},\"wordCount\":388,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Amoytop Biotech\",\"Finance\",\"SHA: 688278\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=64602#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64602\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=64602\",\"name\":\"Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-05-07T05:27:11+00:00\",\"dateModified\":\"2026-05-07T05:27:12+00:00\",\"description\":\"Amoytop Biotech Co. Ltd. (SHA: 688278) released its prospectus for convertible bond issuance to unspecified eligible investors, targeting total proceeds of RMB 1.53 billion (approximately USD 225.3 million). The capital will be allocated across three strategic initiatives: new drug research and development, construction of a Biotech Innovation Integration Center, and expansion and renovation of the company's innovative drug manufacturing facility.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64602#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=64602\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64602#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion - Insight, China&#039;s Pharmaceutical Industry","description":"Amoytop Biotech Co. Ltd. (SHA: 688278) released its prospectus for convertible bond issuance to unspecified eligible investors, targeting total proceeds of RMB 1.53 billion (approximately USD 225.3 million). The capital will be allocated across three strategic initiatives: new drug research and development, construction of a Biotech Innovation Integration Center, and expansion and renovation of the company's innovative drug manufacturing facility.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=64602","og_locale":"en_US","og_type":"article","og_title":"Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion","og_description":"Amoytop Biotech Co. Ltd. (SHA: 688278) released its prospectus for convertible bond issuance to unspecified eligible investors, targeting total proceeds of RMB 1.53 billion (approximately USD 225.3 million). The capital will be allocated across three strategic initiatives: new drug research and development, construction of a Biotech Innovation Integration Center, and expansion and renovation of the company's innovative drug manufacturing facility.","og_url":"https:\/\/flcube.com\/?p=64602","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-07T05:27:11+00:00","article_modified_time":"2026-05-07T05:27:12+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=64602#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=64602"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion","datePublished":"2026-05-07T05:27:11+00:00","dateModified":"2026-05-07T05:27:12+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=64602"},"wordCount":388,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Amoytop Biotech","Finance","SHA: 688278"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=64602#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=64602","url":"https:\/\/flcube.com\/?p=64602","name":"Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-05-07T05:27:11+00:00","dateModified":"2026-05-07T05:27:12+00:00","description":"Amoytop Biotech Co. Ltd. (SHA: 688278) released its prospectus for convertible bond issuance to unspecified eligible investors, targeting total proceeds of RMB 1.53 billion (approximately USD 225.3 million). The capital will be allocated across three strategic initiatives: new drug research and development, construction of a Biotech Innovation Integration Center, and expansion and renovation of the company's innovative drug manufacturing facility.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=64602#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=64602"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=64602#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Amoytop Biotech Launches RMB 1.53 Billion Convertible Bond Offering to Fuel R&amp;D and Manufacturing Expansion"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=64602"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64602\/revisions"}],"predecessor-version":[{"id":64604,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64602\/revisions\/64604"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=64602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=64602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=64602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}